TytoCare vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
TytoCare makes an FDA-cleared AI-powered telehealth examination device and platform that enables clinical-grade remote exams of the heart, lungs, ears, throat, skin, and abdomen; partners with 220+ health systems and payers;
About
TytoCare is a telehealth technology company founded in 2012 by Dedi Gilad and Ofer Tzadik, with headquarters in New York City and R&D operations in Israel. The company has developed an FDA-cleared handheld examination device paired with a digital platform and AI analysis engine that enables patients to conduct guided, clinical-grade medical examinations at home. The TytoCare device integrates a digital stethoscope (for heart and lung auscultation), otoscope (ear), camera (throat, skin, abdomen), and thermometer in a single compact unit. A clinician — joining via the TytoCare telehealth platform — guides the patient or a caregiver through the exam in real time, while the AI engine analyzes audio and visual data to assist with diagnosis and flag clinical findings.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.